Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients

Pathogens and Disease

Volumn 70, Issue 1, 2014, Pages 40-50

  Kolberg, Jan ^a   Aase, Audun ^a   Næss, Lisbeth M ^a   Aaberge, Ingeborg S ^a   Caugant, Dominique A ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Human antibodies; Monoclonal antibodies; Pneumococcal surface protein A; Streptococcus pneumonia; TIGR4

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; PNEUMOCOCCAL SURFACE PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ADULT DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CROSS REACTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SEQUENCE; HUMAN; IMMUNOBLOTTING; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

HUMAN ANTIBODIES; MONOCLONAL ANTIBODIES; PNEUMOCOCCAL SURFACE PROTEIN A; STREPTOCOCCUS PNEUMONIA; TIGR4;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CROSS REACTIONS; HUMANS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84902282569     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12106     Document Type: Article

References (40)

1. Baril L, Briles DE, Crozier P, King J, Punar M, Hollingshead SK & McCormick JB (2004) Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease. Vaccine 23: 789-793.
2. Calbo E & Garau J (2011) Factors affecting the development of systemic inflammatory response syndrome in pneumococcal infections. Curr Opin Infect Dis 24: 241-247.
3. Camilli R, Bonnal RJ, Del GM, Iacono M, Corti G, Rizzi E, Marchetti M, Mulas L, Iannelli F, Superti F, Oggioni MR, De BG & Pantosti A (2011) Complete genome sequence of a serotype 11A, ST62 Streptococcus pneumoniae invasive isolate. BMC Microbiol 11: 25.
4. Donati C, Hiller NL, Tettelin H et al. (2010) Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biol 11: R107.
5. Enright MC & Spratt BG (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144(Pt 11): 3049-3060.
6. Erlich KS & Congeni BL (2012) Importance of circulating antibodies in protection against meningococcal disease. Hum Vaccin Immunother 8: 1029-1035.
7. Gladstone RA, Jefferies JM, Faust SN & Clarke SC (2011) Continued control of pneumococcal disease in the UK - the impact of vaccination. J Med Microbiol 60: 1-8.
8. Goldblatt D, Plikaytis BD, Akkoyunlu M et al. (2011) Establishment of a new human pneumococcal standard reference serum, 007sp. Clin Vaccine Immunol 18: 1728-1736.
9. Hammerschmidt S, Bethe G, Remane PH & Chhatwal GS (1999) Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun 67: 1683-1687.
10. Heeg C, Franken C, van der Linden M, Al-Lahham A & Reinert RR (2007) Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children. Vaccine 25: 1030-1035.
11. Hollingshead SK, Becker R & Briles DE (2000) Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 68: 5889-5900.
12. Hollingshead SK, Baril L, Ferro S, King J, Coan P & Briles DE (2006) Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries. J Med Microbiol 55: 215-221.
13. Hotomi M, Kono M, Hollingshead SK, Briles DE & Yamanaka N (2011) Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A. Adv Otorhinolaryngol 72: 121-125.
14. Jedrzejas MJ, Hollingshead SK, Lebowitz J, Chantalat L, Briles DE & Lamani E (2000) Production and characterization of the functional fragment of pneumococcal surface protein A. Arch Biochem Biophys 373: 116-125.
15. Jonsson S, Musher DM, Chapman A, Goree A & Lawrence EC (1985) Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J Infect Dis 152: 4-13.
16. Kolberg J, Hoiby EA, Aase A, Sletten K, Rodal G, Michaelsen TE & Bucher A (2000) Streptococcus pneumoniae heat shock protein 70 does not induce human antibody responses during infection. FEMS Immunol Med Microbiol 29: 289-294.
17. Kolberg J, Aase A, Michaelsen TE & Rodal G (2001) Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates. FEMS Immunol Med Microbiol 31: 175-180.
18. Kolberg J, Aase A, Rodal G, Littlejohn JE & Jedrzejas MJ (2003) Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling. FEMS Immunol Med Microbiol 39: 265-273.
19. Kolberg J, Aase A, Bergmann S, Herstad TK, Rodal G, Frank R, Rohde M & Hammerschmidt S (2006) Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface. Microbiology 152: 1307-1317.
20. Kolberg J, Ihle O, Thiede B & Aase A (2011) Polyreactivity of monoclonal antibodies made against human erythrocyte membranes with various pathogenic bacteria. Hybridoma (Larchmt) 30: 1-9.
21. Linder A, Hollingshead S, Janulczyk R, Christensson B & Akesson P (2007) Human antibody response towards the pneumococcal surface proteins PspA and PspC during invasive pneumococcal infection. Vaccine 25: 341-345.
22. McDaniel LS, Ralph BA, McDaniel DO & Briles DE (1994) Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb Pathog 17: 323-337.
23. Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ & Briles DE (2012) Pneumococcal surface protein a inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J Immunol 189: 5327-5335.
24. Musher DM, Manoff SB, McFetridge RD, Liss CL, Marchese RD, Raab J, Rueda AM, Walker ML & Hoover PA (2011) Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Hum Vaccin 7: 919-928.
25. Oliveira ML, Miyaji EN, Ferreira DM et al. (2010) Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice. PLoS ONE 5: e10863.
26. Qian J, Yao K, Xue L et al. (2012) Diversity of pneumococcal surface protein A (PspA) and relation to sequence typing in Streptococcus pneumoniae causing invasive disease in Chinese children. Eur J Clin Microbiol Infect Dis 31: 217-223.
27. Quataert SA, Rittenhouse-Olson K, Kirch CS, Hu B, Secor S, Strong N & Madore DV (2004) Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f). Clin Diagn Lab Immunol 11: 1064-1069.
28. Roche H, Hakansson A, Hollingshead SK & Briles DE (2003) Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect Immun 71: 1033-1041.
29. Rolo D, Ardanuy C, Fleites A, Martin R & Linares J (2009) Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain. BMC Microbiol 9: 80.
30. Sadowy E, Skoczynska A, Fiett J, Gniadkowski M & Hryniewicz W (2006) Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland. Clin Vaccine Immunol 13: 139-144.
31. Sanchez CJ, Hinojosa CA, Shivshankar P, Hyams C, Camberlein E, Brown JS & Orihuela CJ (2011) Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence. PLoS ONE 6: e26587.
32. Serrano I, Melo-Cristino J & Ramirez M (2006) Heterogeneity of pneumococcal phase variants in invasive human infections. BMC Microbiol 6: 67.
33. Simell B, Lahdenkari M, Reunanen A, Kayhty H & Vakevainen M (2008) Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin Vaccine Immunol 15: 1391-1397.
34. Tettelin H, Nelson KE, Paulsen IT et al. (2001) Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293: 498-506.
35. van Mens SP, Meijvis SC, Endeman H, van Velzen-Blad H, Biesma DH, Grutters JC, Vlaminckx BJ & Rijkers GT (2011) Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol 18: 796-801.
36. Virolainen A, Russell W, Crain MJ, Rapola S, Kayhty H & Briles DE (2000) Human antibodies to pneumococcal surface protein A in health and disease. Pediatr Infect Dis J 19: 134-138.
37. Waltman WD, McDaniel LS, Gray BM & Briles DE (1990) Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microb Pathog 8: 61-69.
38. Westerink MA, Schroeder HW Jr & Nahm MH (2012) Immune Responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination. Aging Dis 3: 51-67.
39. Yother J & White JM (1994) Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J Bacteriol 176: 2976-2985.
40. Zysk G, Bethe G, Nau R, Koch D, Grafin Von Bassewitz VC, Heinz HP & Reinert RR (2003) Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease. J Infect Dis 187: 330-333.